- Home
- FSCO vs INVA Comparison
FSCO vs INVA Comparison
Compare FSCO & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSCO
- INVA
- Stock Information
- Founded
- FSCO 2013
- INVA 1996
- Country
- FSCO United States
- INVA United States
- Employees
- FSCO N/A
- INVA N/A
- Industry
- FSCO Trusts Except Educational Religious and Charitable
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- FSCO Finance
- INVA Health Care
- Exchange
- FSCO Nasdaq
- INVA Nasdaq
- Market Cap
- FSCO 1.4B
- INVA 1.3B
- IPO Year
- FSCO N/A
- INVA 2004
- Fundamental
- Price
- FSCO $7.42
- INVA $18.72
- Analyst Decision
- FSCO
- INVA Strong Buy
- Analyst Count
- FSCO 0
- INVA 3
- Target Price
- FSCO N/A
- INVA $40.33
- AVG Volume (30 Days)
- FSCO 709.7K
- INVA 947.9K
- Earning Date
- FSCO 01-01-0001
- INVA 08-04-2025
- Dividend Yield
- FSCO 11.44%
- INVA N/A
- EPS Growth
- FSCO N/A
- INVA N/A
- EPS
- FSCO N/A
- INVA N/A
- Revenue
- FSCO N/A
- INVA $369,844,000.00
- Revenue This Year
- FSCO N/A
- INVA $3.75
- Revenue Next Year
- FSCO N/A
- INVA $12.62
- P/E Ratio
- FSCO N/A
- INVA N/A
- Revenue Growth
- FSCO N/A
- INVA 18.70
- 52 Week Low
- FSCO $4.08
- INVA $16.67
- 52 Week High
- FSCO $6.00
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- FSCO 63.72
- INVA 36.02
- Support Level
- FSCO $7.18
- INVA $19.35
- Resistance Level
- FSCO $7.57
- INVA $20.58
- Average True Range (ATR)
- FSCO 0.09
- INVA 0.46
- MACD
- FSCO 0.02
- INVA -0.07
- Stochastic Oscillator
- FSCO 60.26
- INVA 3.63
About FSCO FS Credit Opportunities Corp.
FS Credit Opportunities Corp is a closed-end management investment company. The Fund's primary investment objective is to generate an attractive total return consisting of a high level of current income and capital appreciation, with a secondary objective of capital preservation. It predominantly invests in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments. The credit instruments in which it invests typically are rated below investment grade by rating agencies or would be rated below investment grade if rated. To achieve its investment objectives, the fund focuses on strategies such as Opportunistic Credit, Special Situations, and Capital Structure Solutions.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.